drugset / Trial / NCT07365904
Investigating Ovulation Inhibition for Use as a Contraceptive
RandomizedCrossoverOpen-labelTreatment
Summary
A single-centre, open-label, randomised, phase II study on the maintenance of ovulation inhibition after intentional application errors during 84 days of treatment with MR 130A 01 contraceptive transdermal patch
Timeline
- Start
- 2025-12-22
- Primary completion
- 2026-11-30
- Completion
- 2026-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | norelgestromin | Unknown | — | Other |
Indications
No indication recorded.